ArticleAntibiotics (Basel, Switzerland)2022

Individual Pharmacotherapy Management (IPM)-IV: Optimized Usage of Approved Antimicrobials Addressing Under-Recognized Adverse Drug Reactions and Drug-Drug Interactions in Polypharmacy.

Ursula Wolf et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.